SUPERFICIAL BLADDER TUMORS AND INCREASED REACTIVITY AGAINST MYCOBACTERIAL ANTIGENS BEFORE BACILLUS CALMETTE-GUERIN THERAPY
Alexandre R. Zlotta(University of Toronto), Kris Huygen(Institut Scientifique de Santé Publique), HOSSEIN SHEKARSARAI(Erasmus Hospital), Michel de Cock(Erasmus Hospital), Fabienne Jurion, Kamiel Palfliet(Erasmus Hospital), Claude C. Schulman(Université Libre de Bruxelles), Jean‐Paul Van Vooren(Université Libre de Bruxelles), Jacques Simon(Institut Pasteur), Annie Drowart(Centre Hospitalier Universitaire Brugmann)
Cited by 0
Related Papers
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
|Nature Medicine|1996|632
Newborns Develop a Th1-Type Immune Response to <i>Mycobacterium bovis</i> Bacillus Calmette-Guerin Vaccination
|The Journal of Immunology|1999|405
100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19
|Nature Reviews Urology|2021|154
The consensus molecular classification of muscle-invasive bladder cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2018|153